Chemoinformaics analysis of 3, 7-octadiene-2,6-diol-2,6-dimethyl
| Molecular Weight | 170.252 | nRot | 4 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 2 |
| Exact Molecular Weight | 170.131 | nRing | 0 |
| Solubility: LogS | -0.593 | nHRing | 0 |
| Solubility: LogP | 1.413 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.3063 |
| nHD | 2 | BPOL | 18.0577 |
| QED | 0.63 |
| Synth | 3.882 |
| Natural Product Likeliness | 2.811 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.282 |
| MDCK | 0.0000259 |
| BBB | 0.984 |
| PPB | 0.470745 |
| VDSS | 1.008 |
| FU | 0.486334 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.26 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.775 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.715 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.157 |
| CYP3a4-inh | 0.184 |
| CYP3a4-sub | 0.27 |
| CL | 5.805 |
| T12 | 0.626 |
| hERG | 0.007 |
| Ames | 0.006 |
| ROA | 0.009 |
| SkinSen | 0.502 |
| Carcinogencity | 0.164 |
| EI | 0.995 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.939017 |